The Baseline Serum Lipoprotein Profile Is Related to Plant Stanol Induced Changes in Serum Lipoprotein Cholesterol and Triacylglycerol Concentrations

Journal of the American College of Nutrition

Volumn 27, Issue 1, 2008, Pages 117-126

  Naumann, Elke ^a   Plat, Jogchum ^a   Mensink, Ronald P ^a   Kester, Arnold D M ^b  

^a Department of Human Biology ^*  (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Baseline subject characteristics; LDL cholesterol; Plant stanols; Serum concentrations of plant sterols; Triacylglycerol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STANOL ESTER; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; PLANT; SMOKING;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SITOSTEROLS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 42649086181     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2008.10719683     Document Type: Article

References (38)

1. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R: Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78: 965-978, 2003.
2. Vissers MN, Zock PL, Meijer GW, Katan MB: Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans. Am J Clin Nutr 72: 1510-1515, 2000.
3. Plat J, van Onselen ENM, van Heugten MMA, Mensink RP: Effects on serum lipids, lipoproteins and fat soluble antioxidantconcentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 54: 671-677, 2000.
4. Hallikainen MA, Uusitupa MI: Effects of 2 low-fat stanol estercontaining margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69: 403-410, 1999.
5. Vanhanen HT, Kajander J, Lehtovirta H, Miettinen TA: Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects. Clin Sci (Lond) 87: 61-67, 1994.
6. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MIJ: Comparison of the effects of plant sterol ester and plant stanol esters-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54: 715-725, 2000.
7. Hallikainen MA, Sarkkinen ES, Uusitupa MI: Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 130: 767-776, 2000.
8. Neil HA, Meijer GW, Roe LS: Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterolenriched fat spread. Atherosclerosis 156: 329-337, 2001.
9. Gylling H, Miettinen TA: Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 48: 575-580, 1999.
10. Nguyen TT, Dale LC, von Bergmann K, Croghan IT: Cholesterollowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin Proc 74: 1198-1206, 1999.
11. Andersson A, Karlstrom B, Mohsen R, Vessby B: Cholesterollowering effects of a stanol ester-containing low-fat margarine used in conjunction with a strict lipid-lowering diet. Eur Heart J Supplements 1: S80-S90, 1999.
12. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J: An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 75: 79-86, 2002.
13. Maki KC, Davidson MH, Umporowicz DM, Schaefer, EJ, Dicklin MR, Ingram KA, Chen S, McNamara JR, Gebhart BW, Ribaya-Mercado JD, Perrone G, Robins, SJ, Franke WC: Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 74: 33-43, 2001.
14. Nestel P, Cehun M, Pomeroy S, Abbey M, Weldon G: Cholesterollowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur J Clin Nutr 55: 1084-1090, 2001.
15. Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H: Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr 71: 1095-1102, 2000.
16. Weststrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total-and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52: 334-343, 1998.
17. Judd JT, Baer DJ, Chen SC, Clevidence BA, Muesing RA, Kramer M, Meijer GW: Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids 37: 33-42, 2002.
18. Naumann E, Plat J, Mensink RP: Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet. J Nutr 133: 2741-2747, 2003.
19. Gylling H, Puska P, Vartiainen E, Miettinen TA: Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. J Lipid Res 40: 593-600, 1999.
20. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvonen M, Jauhiainen M, Torstila I, Miettinen TA: Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 34: 1535-1544, 1993.
21. Miettinen TA, Vanhanen H: Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105: 217-226, 1994.
22. Mussner MJ, Parhofer KG, Von Bergmann K, Schwandt P, Broedl U, Otto C: Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 51: 189-194, 2002.
23. Law MR: Plant sterol and stanol margarines and health. West J Med 173: 43-47, 2000.
24. Plat J, Mensink RP: Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis 148: 101-112, 2000.
25. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM: Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 160: 205-213, 2002.
26. Kerckhoffs DAJM: Dietary components and cardiovascular risk markers: effects of tocotrienols, beta-glucan and plant stanol esters. Faculty of Health Sciences, Department of Human Biology, Maastricht University, Maastricht, 2003. [doctoral thesis]
27. Plat J, Mensink RP: Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 50: 520-529, 2001.
28. Weggemans RM, Zock PL, Urgert R, Katan MB: Differences between men and women in the response of serum cholesterol to dietary changes. Eur J Clin Invest 29: 827-834, 1999.
29. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
30. Ketomaki A, Gylling H, Miettinen TA: Non-cholesterol sterols in serum, lipoproteins, and red cells in statin-treated FH subjects off and on plant stanol and sterol ester spread. Clin Chim Acta 353: 75-86, 2005.
31. Gylling H, Miettinen TA: Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37: 773-780, 1994.
32. Rohrer L, Hersberger M, von Eckardstein A: High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15: 269-278, 2004.
33. Despres J-P, Lemieux I, Dagenais G-R, Cantin B, Lamarche B: HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153: 263-272, 2000.
34. Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81: 7B-12B, 1998.
35. NIH Consensus Development Panel on triglyceride, high-density lipoprotein, and coronary heart disease: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269: 505-510, 1993.
36. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E: Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333: 1308-1312, 1995.
37. Thuluva SC, Igel M, Lutjohann D, Sudhop T, Von Bergmann K: Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 43: 305-310, 2005.
38. Sacks FM, Katan MB: Randomized clinical trials on the effects of dietary fat and carbohydrates on plasma lipoproteins and cardiovascular disease. Am J Med 113(9B): 13S-24S, 2002.